Fig. 1From: Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control studyKaplan–Meier analysis for survival with FPV treatment, Group 1: Early treatment with FPV and HQ, Group 2: Late treatment with FPV and HQBack to article page